Vanguard Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Buy
15,071
+1,197
+9% +$123K ﹤0.01% 1713
2026
Q1
$1.51M Buy
+13,874
New +$1.32M ﹤0.01% 1583

Other funds holding LMAT

Vanguard Asset Management's LMAT Position: Q2 2026 in Review

Vanguard Asset Management increased its LeMaitre Vascular (LMAT) stake by 8.6% in Q2 2026, buying an estimated $123K and bringing the position to 15,071 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1713.

Vanguard Asset Management first reported a position in LMAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.51M in Q1 2026. 319 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Vanguard Asset Management held 15,071 shares of LeMaitre Vascular worth $1.45M as of Q2 2026.
  • Vanguard Asset Management bought 1,197 LeMaitre Vascular shares in Q2 2026, an estimated $123K.
  • LeMaitre Vascular made up ﹤0.01% of Vanguard Asset Management's portfolio in Q2 2026, its #1713 holding.
  • Vanguard Asset Management first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's LeMaitre Vascular position peaked at $1.51M in Q1 2026.
  • 319 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.